Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice

Int Immunopharmacol. 2015 Jan;24(1):140-5. doi: 10.1016/j.intimp.2014.10.032. Epub 2014 Nov 11.

Abstract

Hepatitis E virus (HEV) as a recognized zoonotic pathogen has posed global burden on public health, which is exacerbated by lack of efficient vaccine. In this study, we constructed a recombinant (inaQ-ORF2 gene fusion) Lactococcus lactis (L. lactis) strain NZ3900 that expresses and displays the hepatitis E virus antigen ORF2 utilizing an ice uncleation protein-based anchor system. After oral vaccination of BALB/c mice, significantly higher levels of ORF2-specific mucosal IgA and serum IgG were detected and cellular immunity was also induced. These findings further support that L. lactis-based HEV antigen vaccines could be used for human and animal protection against infection.

Keywords: Hepatitis E virus; Ice nucleation protein; Lactococcus lactis; Oral immunization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Bacterial Outer Membrane Proteins / genetics
  • Female
  • Hepatitis E / immunology
  • Hepatitis E / prevention & control*
  • Hepatitis E virus / immunology*
  • Humans
  • Immunity, Cellular
  • Immunity, Mucosal
  • Immunization
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Lactococcus lactis / genetics
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Fusion Proteins / genetics
  • Viral Hepatitis Vaccines / administration & dosage
  • Viral Hepatitis Vaccines / immunology*
  • Viral Proteins / genetics
  • Viral Proteins / immunology*
  • Zoonoses / immunology
  • Zoonoses / prevention & control*

Substances

  • Bacterial Outer Membrane Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • ORF2 protein, Hepatitis E virus
  • Recombinant Fusion Proteins
  • Viral Hepatitis Vaccines
  • Viral Proteins
  • ice nucleation protein